About Polyribonucleotide 5'-hydroxyl-kinase Clp1
Polyribonucleotide 5'-hydroxyl-kinase Clp1 (CLP1) is a protein
from Homo sapiens identified by UniProt accession
Q92989, 425 residues long.
MolForge cross-references it against 0 known binders and
478 disease associations.
Target properties
| Protein name | Polyribonucleotide 5'-hydroxyl-kinase Clp1 |
| UniProt accession | Q92989 |
| Gene | CLP1 |
| Organism | Homo sapiens |
| Length | 425 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (478)
Diseases linked to this target (Open Targets).
- pontocerebellar hypoplasia type 10 · score 0.78
- Non-syndromic pontocerebellar hypoplasia · score 0.27
- pontocerebellar hypoplasia · score 0.27
- genetic disorder · score 0.19
- hepatocellular carcinoma · score 0.18
- gastric intestinal type adenocarcinoma · score 0.18
- breast carcinoma · score 0.18
- colorectal adenocarcinoma · score 0.18
- cutaneous melanoma · score 0.18
- head and neck squamous cell carcinoma · score 0.18
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q92989-F1 | alphafold | PREDICTED | 93.81 | — |
Amino-acid sequence (425 residues)
MGEEANDDKK PTTKFELERE TELRFEVEAS QSVQLELLTG MAEIFGTELT RNKKFTFDAG AKVAVFTWHG CSVQLSGRTE VAYVSKDTPM LLYLNTHTAL EQMRRQAEKE EERGPRVMVV GPTDVGKSTV CRLLLNYAVR LGRRPTYVEL DVGQGSVSIP GTMGALYIER PADVEEGFSI QAPLVYHFGS TTPGTNIKLY NKITSRLADV FNQRCEVNRR ASVSGCVINT CGWVKGSGYQ ALVHAASAFE VDVVVVLDQE RLYNELKRDL PHFVRTVLLP KSGGVVERSK DFRRECRDER IREYFYGFRG CFYPHAFNVK FSDVKIYKVG APTIPDSCLP LGMSQEDNQL KLVPVTPGRD MVHHLLSVST AEGTEENLSE TSVAGFIVVT SVDLEHQVFT VLSPAPRPLP KNFLLIMDIR FMDLK
Explore Polyribonucleotide 5'-hydroxyl-kinase Clp1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets